S100A10 and cancer: P11 overexpression in cancers has been attributed to the presence of oncogenic RAS7 and the promyelocytic leukemia-retinoic acid receptor-alpha (PML/RARα) oncogene present in acute promyelocytic leukemia (APL)9,10.